Research Information System
PEDIATRIC INFECTIOUS DISEASE JOURNAL, vol.42, no.9, pp.745-749, 2023 (SCI-Expanded, Scopus)
Background:We aimed to evaluate the incidence, clinical findings, and risk factors of antibiotic-associated diarrhea (AAD) in hospitalized children without known comorbid diseases. Methods:All hospitalized children during the 1-year period that fulfilled the inclusion criteria were included in this study (n = 358). AAD was defined as; & GE;2 loose or watery stools per day for a minimum of 24 hours during antibiotic treatment caused by Clostridioides difficile or negative stool tests for identifiable infectious agents. Results:During hospitalization, diarrhea developed in 32 (8.93%) of the 358 patients. C. difficile toxin B was positive for 1 case. No infectious agents were detected in 21 patients. Overall, AAD was observed in 22 patients (6.14%, 95% CI: 4.09-9.13). Male sex (P = 0.027, OR: 3.36), age between 1 month and <3 years (P = 0.01, OR: 4.23), ibuprofen use (P = 0.044, OR: 2.63) and late administration of antibiotics (P = 0.001, OR: 9.5) were associated with the development of AAD. Conclusions:The incidence of AAD is low among hospitalized children without comorbid diseases, and most diarrheal episodes are mild and self-limiting. The use of probiotics in this patient group may be limited to certain specific situations.